These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8050633)

  • 21. Predicting the carcinogenicity of chemicals in humans from rodent bioassay data.
    Goodman G; Wilson R
    Environ Health Perspect; 1991 Aug; 94():195-218. PubMed ID: 1954931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database.
    Gold LS; Slone TH
    J Toxicol Environ Health; 1993 May; 39(1):143-57. PubMed ID: 8492327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies.
    Allen DG; Pearse G; Haseman JK; Maronpot RR
    Toxicol Pathol; 2004; 32(4):393-401. PubMed ID: 15307212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of low-incidence brain tumor responses in F344 rats following chemical exposures in National Toxicology Program carcinogenicity studies.
    Sills RC; Hailey JR; Neal J; Boorman GA; Haseman JK; Melnick RL
    Toxicol Pathol; 1999; 27(5):589-99. PubMed ID: 10528639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of human tissue-specific correlations for rodent pancreatic and colorectal carcinogens.
    Card JW; Fikree H; Haighton LA; Lee-Brotherton V; Wan J; Sangster B
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):442-58. PubMed ID: 23069141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordance of carcinogenic response between rodent species: potency dependence and potential underestimation.
    Piegorsch WW; Carr GJ; Portier CJ; Hoel DG
    Risk Anal; 1992 Mar; 12(1):115-21. PubMed ID: 1574611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update of the National Toxicology Program database on nasal carcinogens.
    Haseman JK; Hailey JR
    Mutat Res; 1997 Oct; 380(1-2):3-11. PubMed ID: 9385384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quick estimate of the regulatory virtually safe dose based on the maximum tolerated dose for rodent bioassays.
    Gaylor DW; Gold LS
    Regul Toxicol Pharmacol; 1995 Aug; 22(1):57-63. PubMed ID: 7494904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of rodent carcinogenicity using the DEREK system for 30 chemicals currently being tested by the National Toxicology Program. The DEREK Collaborative Group.
    Marchant CA
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1065-73. PubMed ID: 8933056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doses in rodent cancer studies: sorting fact from fiction.
    Bucher JR
    Drug Metab Rev; 2000 May; 32(2):153-63. PubMed ID: 10774772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology Program.
    Crump KS; Krewski D; Van Landingham C
    Environ Health Perspect; 1999 Jan; 107(1):83-8. PubMed ID: 9872721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.
    Ashby J; Tennant RW
    Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.
    Nesnow S
    Mutat Res; 1990 Sep; 239(2):83-115. PubMed ID: 2385240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of rodent carcinogenicity of further 30 chemicals bioassayed by the U.S. National Toxicology Program.
    Benigni R; Andreoli C; Zito R
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1041-4. PubMed ID: 8933052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP.
    Sasaki YF; Fujikawa K; Ishida K; Kawamura N; Nishikawa Y; Ohta S; Satoh M; Madarame H; Ueno S; Susa N; Matsusaka N; Tsuda S
    Mutat Res; 1999 Mar; 440(1):1-18. PubMed ID: 10095124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The case for an upper dose limit of 1000 mg/kg in rodent carcinogenicity tests.
    Davies TS; Montro A
    Cancer Lett; 1995 Aug; 95(1-2):69-77. PubMed ID: 7656246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009).
    Friedrich A; Olejniczak K
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):225-48. PubMed ID: 21513764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.